- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05080608
Nerve Injury in the Hand, an Interview Study
Patients´ Experiences of Changed Physical Activity Level Following Nerve Injury in the Upper Limb- a Qualitative Study
Study Overview
Detailed Description
Aim:
Has the physical activity level changed in connection with the nerve injury. Experiences of factors influensing this change.
Population: Patients surgically treated for digital,median,ulnar-or plexus nerveinjuries at Södersjukhuset or Universitets sjukhuset in Linköping. 1-3 years ago. Age 18-75.
Method: Interviews are carried out over the phone, digitally recorded and trascribed. The analysis is inductive approach.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 11883
- Karolinska institutet södersjukhuset
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Injury to the median, ulnar or digital nerve or injury to the brachial plexus.
- 1-5 years post injury.
Exclusion Criteria:
- Severe psychiatric disease.
- Drug or alcohol abuse.
- Insufficient language understanding.
- Severe diabetes mellitus with nerve complications.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Nerve injury
This is an interview study of patients with injury to the median, ulnar or digital nerve or brachial plexus injury.
|
Treatment according to clinical practise
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interview
Time Frame: 1-5 years post injury
|
A semi structured interview will be conducted, utilizing semi structured interview.
Themes regarding changes in physical activity related to the nerve injury will be presented.
|
1-5 years post injury
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Marianne Arner, Professor, Karolinska Institutet
- Principal Investigator: Cecilia Mellstrand Navarro, PhD, Karolinska Institutet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Nerve injury interview
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.